This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Will Clorox's (CLX) 2020 Strategy Help Improve Q1 Earnings?
by Zacks Equity Research
Clorox (CLX) is riding on its 2020 Strategy, cost containment efforts and other growth initiatives. However, it remains vulnerable to the threats of rising commodity costs and stiff competition.
Why Is Clorox (CLX) Up 2.4% Since the Last Earnings Report?
by Zacks Equity Research
Clorox (CLX) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
Clorox (CLX) Q4 Earnings & Sales Beat the Zacks Consensus
by Zacks Equity Research
The Clorox Company (CLX) released 4Q17 results, wherein earnings benefited from strong sales and cost savings. Sales were backed by favorable volumes and pricing.
Clorox (CLX) Tops Q4 Earnings & Sales, Initiates FY18 View
by Zacks Equity Research
The Clorox Company (CLX) reported fourth-quarter fiscal 2017 results, wherein adjusted earnings from continuing operations of $1.53 per share rose 21% year over year and also beat the Zacks Consensus Estimate of $1.49.
Consumer Staples Stocks Earnings Roster for Aug 3: CLX, CHD
by Zacks Equity Research
Let's take a look at a couple of Consumer Staples stocks that are queued up for earnings releases on Aug 3.
Why Earnings Season Could Be Great for Clorox (CLX)
by Zacks Equity Research
Clorox (CLX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Stericycle (SRCL) to Report Q2 Earnings: What Lies Ahead?
by Zacks Equity Research
Focus on increasing operational efficiency and continuous investments in data analytic capabilities to improve its performance are likely to drive Stericycle's (SRCL) Q2 earnings.
Will Declining Volumes Hurt Altria's (MO) Earnings in Q2?
by Zacks Equity Research
Despite strong brand portfolio, we believe declining demand for cigarettes due to the ongoing anti-tobacco campaigns and rising cigarette prices will continue to hurt Altria's (MO) earnings.
What's in Store for Philip Morris (PM) this Earnings Season?
by Zacks Equity Research
We expect Philip Morris' (PM) smoke-free efforts to help second-quarter earnings, offsetting the impact of cigarette volume declines.
Retail in Transformation Mode: Will Players Benefit?
by Zacks Equity Research
With respect to seasonal shopping periods, it is that time of the year when retailers are getting ready for a major spending event: Back-to-School.
4 Reasons to Retain Clorox (CLX) Stock in Your Portfolio
by Zacks Equity Research
Clorox Inc. (CLX) is doing well on the back of its solid surprise trend, robust outlook, impressive stock performance, progress on 2020 Strategy, diversified brand portfolio and disciplined capital strategy.
What's Keeping Clorox Ticking Even a Month After Earnings?
by Zacks Equity Research
Consumer products seller, Clorox Inc. (CLX) is going strong since reporting robust third-quarter fiscal 2017 results last month.
Why Is Clorox (CLX) Up 2.6% Since the Last Earnings Report?
by Zacks Equity Research
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Company News for May 04, 2017
by Zacks Equity Research
Companies in the News are: YUM,CLX,RAI,HUM
Clorox (CLX) Beats on Q3 Earnings, Updates View
by Zacks Equity Research
The Clorox Company (CLX) reported third-quarter fiscal 2017 results, wherein adjusted earnings from continuing operations of $1.31 per share rose 8% year over year and also beat the Zacks Consensus Estimate of $1.30.
What is Driving Clorox's (CLX) Momentum Post Q2 Earnings?
by Zacks Equity Research
The second quarter of fiscal 2017 marked a comeback for the consumer goods behemoth The Clorox Company (CLX) as there has been no looking back for the stock since then.
Why Is Clorox Company (CLX) Up 13.9% Since the Last Earnings Report?
by Zacks Equity Research
Clorox Company (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Clorox (CLX) Stock Up 5.6% Since Q2 Earnings: Here's Why
by Zacks Equity Research
Shares of Clorox (CLX) jumped 5.6% since the company released robust second-quarter fiscal 2017 results.
Stronger Jobs at 227K, Unemployment Ticks Up to 4.8%
by Mark Vickery
227K new jobs created in the month of January, up from the consensus 174K expected from analysts.
Clorox (CLX) Amends FY17 View on Robust Q2 Earnings & Sales
by Zacks Equity Research
The Clorox Company (CLX) released solid second-quarter fiscal 2017 results, wherein both top line and bottom line surpassed our estimate and grew year over year.
Clorox (CLX) Beats Q2 Earnings & Revenues, Updates View
by Zacks Equity Research
The Clorox Company (CLX) reported second-quarter fiscal 2017 results, wherein adjusted earnings from continuing operations of $1.25 per share rose 9.6% year over year and also beat the Zacks Consensus Estimate of $1.14.
Consumer Staples Stocks for Earnings on Feb 3: CLX, HSY
by Zacks Equity Research
Let's see what awaits the following Consumer Staples stocks that are queued up for earnings releases on Feb 3.
Why Earnings Season Could Be Great for The Clorox Company (CLX)
by Zacks Equity Research
The Clorox Company (CLX) looks like an exciting pick for investors as it is poised to beat at earnings season.
Can Hershey (HSY) Spring a Surprise this Earnings Season?
by Zacks Equity Research
The Hershey Company (HSY) is slated to report fourth-quarter 2016 results on Feb 3, before the opening bell.
The Zacks Analyst Blog Highlights: Clorox, Estee Lauder and Coty
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Clorox, Estee Lauder and Coty